DE69231093D1 - Verwendung einer zellulären Zusammensetzung zur Behandlung von menschlichen oder tierischen Organismen - Google Patents

Verwendung einer zellulären Zusammensetzung zur Behandlung von menschlichen oder tierischen Organismen

Info

Publication number
DE69231093D1
DE69231093D1 DE69231093T DE69231093T DE69231093D1 DE 69231093 D1 DE69231093 D1 DE 69231093D1 DE 69231093 T DE69231093 T DE 69231093T DE 69231093 T DE69231093 T DE 69231093T DE 69231093 D1 DE69231093 D1 DE 69231093D1
Authority
DE
Germany
Prior art keywords
treatment
human
animal organisms
compositions
cellular composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69231093T
Other languages
English (en)
Other versions
DE69231093T2 (de
Inventor
Claude Roth
Lluis Mir
Philippe Kourilsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut Pasteur de Lille
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9418997&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69231093(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Institut Pasteur de Lille, Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut Pasteur de Lille
Publication of DE69231093D1 publication Critical patent/DE69231093D1/de
Application granted granted Critical
Publication of DE69231093T2 publication Critical patent/DE69231093T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5156—Animal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins
    • A61K2039/55533—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69231093T 1991-11-15 1992-11-13 Verwendung einer zellulären Zusammensetzung zur Behandlung von menschlichen oder tierischen Organismen Expired - Fee Related DE69231093T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9114119A FR2683725B1 (fr) 1991-11-15 1991-11-15 Composition cellulaire pour le traitement des organismes humains ou animaux.
PCT/FR1992/001061 WO1993010219A1 (fr) 1991-11-15 1992-11-13 Composition cellulaire pour le traitement des organismes humains ou animaux

Publications (2)

Publication Number Publication Date
DE69231093D1 true DE69231093D1 (de) 2000-06-29
DE69231093T2 DE69231093T2 (de) 2001-02-01

Family

ID=9418997

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69231093T Expired - Fee Related DE69231093T2 (de) 1991-11-15 1992-11-13 Verwendung einer zellulären Zusammensetzung zur Behandlung von menschlichen oder tierischen Organismen

Country Status (13)

Country Link
US (1) US6074637A (de)
EP (1) EP0579791B1 (de)
JP (2) JPH06504450A (de)
AT (1) ATE193323T1 (de)
AU (1) AU671090B2 (de)
CA (1) CA2098720C (de)
DE (1) DE69231093T2 (de)
DK (1) DK0579791T3 (de)
ES (1) ES2146226T3 (de)
FR (1) FR2683725B1 (de)
GR (1) GR3034192T3 (de)
SG (1) SG48066A1 (de)
WO (1) WO1993010219A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5662896A (en) * 1988-03-21 1997-09-02 Chiron Viagene, Inc. Compositions and methods for cancer immunotherapy
DE4303751C1 (de) * 1993-02-09 1994-09-08 Intracon Sarl Verfahren zur Wiederverwertung von Filterstäuben
WO1994018995A1 (en) * 1993-02-17 1994-09-01 Sloan-Kettering Institute For Cancer Research Allogeneic vaccine and method to synthesize same
US20050169900A1 (en) * 1993-02-17 2005-08-04 Sloan Kettering Institute For Cancer Research Allogeneic vaccine and methods to synthesize same
FR2709309B1 (fr) * 1993-08-25 1995-11-10 Centre Nat Rech Scient Compositions cellulaires, préparation et utilisations thérapeutiques.
AUPM543894A0 (en) * 1994-05-04 1994-05-26 Commonwealth Scientific And Industrial Research Organisation An adjuvant
US6730512B2 (en) 1997-04-09 2004-05-04 Amdl, Inc. Combination immunogene therapy
IL132164A0 (en) * 1997-04-09 2001-03-19 Chang Lung Ji Animal model for evaluation of vaccines
AU741602B2 (en) * 1998-02-02 2001-12-06 Johns Hopkins University School Of Medicine, The A universal immunomodulatory cytokine-expressing bystander cell line and related compositions and methods of manufacture and use
AU2002360540A1 (en) * 2001-12-04 2003-06-17 University Of Southern California Method for intracellular modifications within living cells using pulsed electric fields
TWI776276B (zh) * 2019-11-13 2022-09-01 中國醫藥大學 異種組織細胞組合物治療癌症之用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783407A (en) * 1985-09-30 1988-11-08 Merck & Co., Inc. Growth of hepatitus A virus in vero cells
US5219740A (en) * 1987-02-13 1993-06-15 Fred Hutchinson Cancer Research Center Retroviral gene transfer into diploid fibroblasts for gene therapy
JPH04507041A (ja) * 1988-12-13 1992-12-10 アメリカ合衆国 遺伝工学により修飾された内皮細胞およびその利用方法
WO1992005262A1 (en) * 1990-09-14 1992-04-02 The John Hopkins University Methods and compositions for genetic therapy and potentiation of anti-tumor immunity
US5358866A (en) * 1991-07-03 1994-10-25 The United States Of America As Represented By The Department Of Health And Human Services Cytosine deaminase negative selection system for gene transfer techniques and therapies
CA2121487A1 (en) * 1991-10-21 1993-04-29 Stephen A. Sherwin Combined cellular and immunosuppresive therapies

Also Published As

Publication number Publication date
EP0579791A1 (de) 1994-01-26
SG48066A1 (en) 1998-04-17
CA2098720C (fr) 2003-01-21
JP2004026802A (ja) 2004-01-29
AU3163193A (en) 1993-06-15
ES2146226T3 (es) 2000-08-01
EP0579791B1 (de) 2000-05-24
DK0579791T3 (da) 2000-10-30
FR2683725B1 (fr) 1995-07-07
GR3034192T3 (en) 2000-11-30
AU671090B2 (en) 1996-08-15
JPH06504450A (ja) 1994-05-26
CA2098720A1 (fr) 1993-05-16
FR2683725A1 (fr) 1993-05-21
ATE193323T1 (de) 2000-06-15
US6074637A (en) 2000-06-13
WO1993010219A1 (fr) 1993-05-27
DE69231093T2 (de) 2001-02-01

Similar Documents

Publication Publication Date Title
DE69127175D1 (de) Antisens-Oligonukleotide zur Behandlung von Krebs
ATE193323T1 (de) Verwendung einer zellulären zusammensetzung zur behandlung von menschlichen oder tierischen organismen
ATE450268T1 (de) G-csf zur behandlung von amyotropher lateralsklerose
FI844510A0 (fi) Ensym-resistenta immunsystemet modulerande peptider.
DE69328438D1 (de) Eichenrindenextraktverwandte synthetische zubereitungen und verfahren zur verwendung
ATE311853T1 (de) Verwendung von krillenzymen zur behandlung von zahnbelag
DE69902523D1 (de) Verwendung von erythropoietin zur behandlung von multiple myelom
ATE433461T1 (de) Rana pipiens proteine und deren verwendung in der behandlung von tumoren
DE69510356D1 (de) Anti-sickling beta-globin,zusammensetzung und verfahren zur behandlung von sichelzellanämie
SE8500470L (sv) Kompositioner for kosmetiskt, helso- och kroppsbevarande bruk
DK0574394T3 (da) I den humane terapi anvendelige stoffer af polypeptidnatur
DE69933581D1 (de) Verwendung von humanem wachstumshormon zur vermehrung der anzahl zirkulierender cd34+ zellen, zur wiederherstellung des hämapoietischen- und des immunsystems nach myeloablativer oder antiblastischer therapie, bei transplantation oder re-infusion
PH11198A (en) 4-(3,4-methylene dioxy phenyl)-piperidines,composition containing them and to method of treating pain to animal in need of such treatment
DE69427188D1 (de) Zusammensetzung zur behandlung von tumoren und immunisierung von organismen gegen tumore
ES2067948T3 (es) Compuestos biologicamente activos procedentes de algas verde-azuladas.
KR940702380A (ko) 종양 및 육종의 치료 방법(A Method for the treatment of Tumours and Sarcomas)
DE3485773D1 (de) Aus kultivierten mesenchymzellen extrahierte makromolekuele zur behandlung von degenerationskrankheiten.
Brown et al. Aquaculture as a Method for Meeting Hatchery Discharge Standards.
DE60020352D1 (de) Zusammensetzung und methode zur induzierung von apoptosis in prostatakrebszellen mittels m-dna und mcc
ATE49965T1 (de) Verwendung von 2-beta-d-ribofuranosylthiazol-4carboxamiden zur herstellung von medikamenten zur behandlung von krebsartigen tumoren.
IT1244459B (it) Composizione terapeutica per il trattamento di malattie della pelle quali vitiligine,acne,psoriasi,alopecia,ipotricosi
ATE28551T1 (de) Verwendung eines mittels zur antimikrobiellen behandlung von lebens- und futtermitteln.
HU174705B (hu) Apparat dlja oroshenija i opryskivanija rastenijj zhidkimi kemikalijami v zakrytykh teplicakh, prezhde vsego v teplicakh s plenochnym pokrytiem
UA10281C2 (uk) Спосіб отримання речовини для лікування захворювань підшлункової залози

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee